22. Mathiasen AB, Qayyum AA, Jørgensen E, et al. Bone marrow-derived
mesenchymal stromal cell treatment in patients with severe ischaemic heart
failure: A randomized placebo-controlled trial (MSC-HF trial). Eur Heart J. 2015;
36(27): 1744-1753. doi: 10.1093/eurheartj/ehv136.
23. Perin EC, Borow KM, Silva GV, et al. A phase II dose-escalation study
of allogeneic mesenchymal precursor cells in patients with ischemic or
nonischemic heart failure. Circ Res. 2015; 117(6): 576-584. doi:
10.1161/CIRCRESAHA.115.306332.
24. Perin EC, Dohmann HF, Borojevic, et al. Transendocardial, autologous
bone marrow cell transplantation for severe, chronic Ischemic heart failure.
Circulation. 2003; 107(18): 2294-2302.
25. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-
Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive
heart failure. Cochrane Database Syst Rev. 2014; (4): CD007888. doi:
10.1002/14651858.CD007888.pub2.
26. Fisher SA, Doree C, Mathur A, Martin-Rendon E. Meta-Analysis of cell
therapy trials for patients with heart failure. Circ Res. 2015; 116(8): 1361-1377.
doi: 10.1161/CIRCRESAHA.116.304386.
27. Ichim TE, Solano F, Lara F, et al. Combination stem cell therapy for
heart failure. Int Arch Med. 2010; 3(1): 5. doi: 10.1186/1755-7682-3-5.
28. Tuma J, Carrasco A, Castillo J, et al. RESCUE-HF trial: Retrograde
delivery of Allogeneic Umbilical cord lining Sub-Epithelial cells in patients with
heart failure. Cell Transplant. 2016; January. [Epub ahead of print]
29. Silvestre JS, Menasché P. The evolution of the stem cell theory for heart
failure.
EBioMedicine.
2015;
2(12):
1871-1879.
doi:
10.1016/j.ebiom.2015.11.010.
30. Menasché P. Stem cells for the treatment of heart failure. Philos Trans R
Soc Lond B Biol Sci. 2015; 370(1680): 20140373. doi: 10.1098/rstb.2014.0373.
31. Poglajen G, Vrtovec B. Stem cell therapy for chronic heart failure. Curr
Opin Cardiol. 2015; 30(3): 301-310. doi: 10.1097/HCO.0000000000000167.
